Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
AGN Announcements
ARG-007 Efficacious Dose Validated in…
AGN
ARGENICA THERAPEUTICS LIMITED
Market sensitive
ARG-007 Efficacious Dose Validated in New Preclinical Study
Date and time
25 November 2025 at 8:16 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
AGN announcement history
Recent AGN announcements
Notification of cessation of securities - AGN
Investor Presentation - Techknow Conference
Quarterly Activities/Appendix 4C Cash Flow Report
ARG007 Shows Significant Neuroprotection in Concussion Study
Investor Webinar
Investor Presentation